Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
Recruiting now
Conditions studied: Pneumonia, Sepsis, Shock, Septic
In brief
Pneumonia is a common infectious disease of the lung, often requiring treatment in the hospital. Clinical scoring systems are available, identifying patients not requiring hospitalization. However, the course of disease of patients in the hospital remains hard to predict. While most patients will recover quickly, some will, despite appropriate treatment, develop a severe course leading to sepsis and systemic responses resulting in organ dysfunction. The PROGRESS consortium aims to identify clinical, genetic, and other molecular markers and combinations there of predicting a severe course of pneumonia in the hospital. Such predictors will, for instance, support decisions on earlier transfer of patients to intensive care and thus improving outcome. PROGRESS-COMORB aims to extend findings from the previous PROGRESS study to patients with more severe preexisting conditions and immunosuppression.
Key facts
- Study ID
- NCT05688774
- Run by
- Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
- People needed
- 300
- Starts
- 2022-02-28
- Expected to finish
- 2028-02-28
- Last updated by the study team
- 2024-03-13
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hospitalization with community acquired pneumonia (CAP) confirmed by pulmonary infiltrate in chest imaging
- Valid informed consent form
- Working diagnosis of CAP by enrolling physician
- No hospitalization for any reason within 28 days prior to hospitalization for the current episode of CAP
- At least 2 out of the five following clinical symptoms:
- Fever
- Cough
- Purulent sputum
- Shortness of breath or need for respiratory support
- Crackling or rales on auscultation, dullness to percussion, or bronchial breathing
- At least 1 of the following criteria
- Known HIV infection or AIDS
- Anti-tumor treatment within the past six months
- Therapy with corticosteroids ≥ 20mg for ≥ 14 days before enrollment
- Non-steroidal immunosuppressive therapy within the past six months
- Cytostatic therapy within the past six months
- Radiation therapy within the past six months
- Bone marrow transplant received
- Respiratory support at home via tracheostoma
- Cystic fibrosis
- Heart failure: New York Heart Association (NYHA) Stadium IV or HFrEF (defined as left ventricular ejection fraction <40%).
- Decompensated liver disease (Child-Pugh class C)
- Diabetes mellitus with HbA1c ≥ 8,5 %
- End-stage renal disease requiring dialysis
- Pulmonary hypertension (all classes) with mPAP > 20 mmHg (right heart catheter)
You may not qualify if…
- Participation in this study at an earlier time
- More than 48 hours in the hospital before enrollment (for patients directly to intensive care: more than 7 days)
- Pregnancy
- Breastfeeding
- Active tuberculosis
- Acute lung injury or acute respiratory distress syndrome for extrapulmonary reasons
- Massive aspiration
- Sepsis with extrapulmonary focus
- Acute pulmonary embolism
Where it is running
- Charité - Universitätsmedizin Berlin, Medizinische Klinik m. S. Infektiologie und Pneumologie — Berlin, Germany (enrolling)
- Humboldt-Klinikum Vivantes, Kardiologie und kons. Intensivmedizin — Berlin, Germany (enrolling)
- Gemeinschaftskrankenhaus Havelhöhe, Kardio-Pneumologie — Berlin, Germany (enrolling)
- Städtisches Klinikum Dessau, Innere Medizin — Dessau, Germany (enrolling)
- Universitätsklinikum Hamburg Eppendorf, Onkologisches Zentrum, Pneumologische Studienzentrale — Hamburg, Germany (enrolling)
- Universitätsklinikum Leipzig, Klinik für Onkologie, Gastroenterologie, Hepatologie, Pneumologie — Leipzig, Germany (enrolling)
- Klinikum St. Georg gGmbH, Klinik für Infektions-/Tropenmedizin und Nephrologie — Leipzig, Germany (enrolling)
- Universitätsklinikum Gießen und Marburg, Klinik für Pneumologie und Anästhesie — Marburg, Germany (enrolling)
- Universitätsklinikum Münster, Kardiologie 1 — Münster, Germany (enrolling)
- Diakoniekrankenhaus Rotenburg(Wümme)gGmbH, Zentrum für Pneumologie — Rotenburg (Wümme), Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.